|
Fusion gene ID: 37165 |
FusionGeneSummary for TANC2_ACE |
Fusion gene summary |
Fusion gene information | Fusion gene name: TANC2_ACE | Fusion gene ID: 37165 | Hgene | Tgene | Gene symbol | TANC2 | ACE | Gene ID | 26115 | 1636 |
Gene name | tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 | angiotensin I converting enzyme | |
Synonyms | ROLSA|rols | ACE1|CD143|DCP|DCP1 | |
Cytomap | 17q23.2-q23.3 | 17q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | protein TANC2putative ankyrin-repeat containing proteinrolling pebbles homolog Btetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2 | angiotensin-converting enzymeCD143 antigenangiotensin I converting enzyme (peptidyl-dipeptidase A) 1angiotensin converting enzyme, somatic isoformcarboxycathepsindipeptidyl carboxypeptidase 1dipeptidyl carboxypeptidase Ikininase IIpeptidase P | |
Modification date | 20180519 | 20180527 | |
UniProtAcc | Q9HCD6 | P12821 | |
Ensembl transtripts involved in fusion gene | ENST00000424789, ENST00000389520, | ENST00000538928, ENST00000584529, ENST00000290866, ENST00000428043, ENST00000490216, ENST00000577647, ENST00000290863, ENST00000421982, ENST00000413513, | |
Fusion gene scores | * DoF score | 26 X 12 X 11=3432 | 5 X 5 X 4=100 |
# samples | 27 | 5 | |
** MAII score | log2(27/3432*10)=-3.66801824044871 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/100*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TANC2 [Title/Abstract] AND ACE [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | ACE | GO:0042447 | hormone catabolic process | 7876104 |
Tgene | ACE | GO:0043171 | peptide catabolic process | 4322742|15283675 |
Tgene | ACE | GO:0050435 | amyloid-beta metabolic process | 18495113|19773553 |
Tgene | ACE | GO:0050482 | arachidonic acid secretion | 17077303 |
Tgene | ACE | GO:0060177 | regulation of angiotensin metabolic process | 1851160 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-D8-A1JJ-01A | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000424789 | ENST00000538928 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000424789 | ENST00000584529 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000424789 | ENST00000290866 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000424789 | ENST00000428043 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000424789 | ENST00000490216 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000424789 | ENST00000577647 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000424789 | ENST00000290863 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-5UTR | ENST00000424789 | ENST00000421982 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-5UTR | ENST00000424789 | ENST00000413513 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000389520 | ENST00000538928 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000389520 | ENST00000584529 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000389520 | ENST00000290866 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000389520 | ENST00000428043 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000389520 | ENST00000490216 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000389520 | ENST00000577647 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-intron | ENST00000389520 | ENST00000290863 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-5UTR | ENST00000389520 | ENST00000421982 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
5CDS-5UTR | ENST00000389520 | ENST00000413513 | TANC2 | chr17 | 61457187 | + | ACE | chr17 | 61563918 | + |
Top |
FusionProtFeatures for TANC2_ACE |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
TANC2 | ACE |
Converts angiotensin I to angiotensin II by release ofthe terminal His-Leu, this results in an increase of thevasoconstrictor activity of angiotensin. Also able to inactivatebradykinin, a potent vasodilator. Has also a glycosidase activitywhich releases GPI-anchored proteins from the membrane by cleavingthe mannose linkage in the GPI moiety. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TANC2_ACE |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TANC2_ACE |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
TANC2 | LATS2, YWHAB, PPP1CC, PPP1CA, XPO1, NR2C2, BRAP, CDC5L, ZYX, PAK7, KCTD3, KIF13B, CGN, ZBTB21, KSR1, GIGYF1, LPIN3, MAPRE1, LRFN1, RTKN, DENND4C, MAST3, SH3RF3, DENND1A, SH3PXD2A, SRGAP2, PPM1H, PTPN13, RALGPS2, EIF4E2, SIPA1L1, NF1, CDC25C, CBY1, GIGYF2, INPP5E | ACE | MYH9, CSNK2A1, ACTB, BDKRB2, LMNA, AGT, EWSR1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TANC2_ACE |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | ACE | P12821 | DB00178 | Ramipril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB00492 | Fosinopril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB00519 | Trandolapril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB00691 | Moexipril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB00790 | Perindopril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB01180 | Rescinnamine | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB01197 | Captopril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB01340 | Cilazapril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB01348 | Spirapril | Angiotensin-converting enzyme | small molecule | approved |
Tgene | ACE | P12821 | DB00542 | Benazepril | Angiotensin-converting enzyme | small molecule | approved|investigational |
Tgene | ACE | P12821 | DB00722 | Lisinopril | Angiotensin-converting enzyme | small molecule | approved|investigational |
Tgene | ACE | P12821 | DB00881 | Quinapril | Angiotensin-converting enzyme | small molecule | approved|investigational |
Tgene | ACE | P12821 | DB00584 | Enalapril | Angiotensin-converting enzyme | small molecule | approved|vet_approved |
Top |
RelatedDiseases for TANC2_ACE |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | ACE | C0002395 | Alzheimer's Disease | 4 | CTD_human |
Tgene | ACE | C0005586 | Bipolar Disorder | 4 | PSYGENET |
Tgene | ACE | C0011881 | Diabetic Nephropathy | 4 | CTD_human |
Tgene | ACE | C0036341 | Schizophrenia | 4 | PSYGENET |
Tgene | ACE | C0001973 | Alcoholic Intoxication, Chronic | 3 | PSYGENET |
Tgene | ACE | C0007222 | Cardiovascular Diseases | 3 | CTD_human |
Tgene | ACE | C0344315 | Depressed mood | 3 | PSYGENET |
Tgene | ACE | C0010200 | Coughing | 2 | CTD_human |
Tgene | ACE | C0017661 | IGA Glomerulonephritis | 2 | CTD_human |
Tgene | ACE | C0020538 | Hypertensive disease | 2 | CTD_human |
Tgene | ACE | C0022661 | Kidney Failure, Chronic | 2 | CTD_human |
Tgene | ACE | C0027051 | Myocardial Infarction | 2 | CTD_human |
Tgene | ACE | C0041696 | Unipolar Depression | 2 | PSYGENET |
Tgene | ACE | C0266313 | Allanson Pantzar McLeod syndrome | 2 | CTD_human;HPO;ORPHANET |
Tgene | ACE | C1269683 | Major Depressive Disorder | 2 | PSYGENET |
Tgene | ACE | C0001418 | Adenocarcinoma | 1 | CTD_human |
Tgene | ACE | C0001925 | Albuminuria | 1 | CTD_human |
Tgene | ACE | C0003811 | Cardiac Arrhythmia | 1 | CTD_human |
Tgene | ACE | C0004238 | Atrial Fibrillation | 1 | CTD_human |
Tgene | ACE | C0004352 | Autistic Disorder | 1 | CTD_human |
Tgene | ACE | C0005138 | Berylliosis | 1 | CTD_human |
Tgene | ACE | C0007786 | Brain Ischemia | 1 | CTD_human |
Tgene | ACE | C0010068 | Coronary heart disease | 1 | CTD_human |
Tgene | ACE | C0011071 | Sudden death | 1 | CTD_human |
Tgene | ACE | C0011581 | Depressive disorder | 1 | PSYGENET |
Tgene | ACE | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Tgene | ACE | C0013182 | Drug Allergy | 1 | CTD_human |
Tgene | ACE | C0017205 | Gaucher Disease | 1 | CTD_human |
Tgene | ACE | C0017924 | Glycogen Storage Disease Type V | 1 | CTD_human |
Tgene | ACE | C0018801 | Heart failure | 1 | CTD_human |
Tgene | ACE | C0020542 | Pulmonary Hypertension | 1 | CTD_human |
Tgene | ACE | C0020649 | Hypotension | 1 | CTD_human;HPO |
Tgene | ACE | C0021295 | Infant, Premature, Diseases | 1 | CTD_human |
Tgene | ACE | C0021364 | Male infertility | 1 | CTD_human |
Tgene | ACE | C0022658 | Kidney Diseases | 1 | CTD_human |
Tgene | ACE | C0024115 | Lung diseases | 1 | CTD_human |
Tgene | ACE | C0024121 | Lung Neoplasms | 1 | CTD_human |
Tgene | ACE | C0025303 | Meningococcal Infections | 1 | CTD_human |
Tgene | ACE | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
Tgene | ACE | C0032310 | Pneumonia, Viral | 1 | CTD_human |
Tgene | ACE | C0032914 | Pre-Eclampsia | 1 | CTD_human |
Tgene | ACE | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | ACE | C0033941 | Psychoses, Substance-Induced | 1 | CTD_human |
Tgene | ACE | C0035242 | Respiratory Tract Diseases | 1 | CTD_human |
Tgene | ACE | C0038160 | Staphylococcal Infections | 1 | CTD_human |
Tgene | ACE | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | ACE | C0038454 | Cerebrovascular accident | 1 | CTD_human |
Tgene | ACE | C0043094 | Weight Gain | 1 | CTD_human |
Tgene | ACE | C0086132 | Depressive Symptoms | 1 | PSYGENET |
Tgene | ACE | C0149721 | Left Ventricular Hypertrophy | 1 | CTD_human |
Tgene | ACE | C0221765 | Chronic schizophrenia | 1 | PSYGENET |
Tgene | ACE | C0400966 | Non-alcoholic Fatty Liver Disease | 1 | CTD_human |
Tgene | ACE | C0455503 | H/O: depression | 1 | PSYGENET |
Tgene | ACE | C0948480 | Coronary Restenosis | 1 | CTD_human |
Tgene | ACE | C1175175 | Severe Acute Respiratory Syndrome | 1 | CTD_human |
Tgene | ACE | C1565489 | Renal Insufficiency | 1 | CTD_human |
Tgene | ACE | C1839839 | MAJOR AFFECTIVE DISORDER 2 | 1 | PSYGENET |
Tgene | ACE | C1956346 | Coronary Artery Disease | 1 | CTD_human |
Tgene | ACE | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | ACE | C2937358 | Cerebral Hemorrhage | 1 | CTD_human |